{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T13:46:01Z","timestamp":1794750361267,"version":"4.9.1"},"reference-count":32,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2008,2,25]],"date-time":"2008-02-25T00:00:00Z","timestamp":1203897600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Haemophilia"],"published-print":{"date-parts":[[2008,5]]},"abstract":"<jats:p><jats:bold>Summary.\u00a0<\/jats:bold> The aim of this study was to characterize the adequacy and longevity of biological response to desmopressin (DDAVP) in a large Amish kindred of Type 2M von Willebrand disease (VWD) possessing C\u2010to\u2010T transition at nucleotide 4120 in exon 28 of A1 domain of von Willebrand factor (VWF) gene. Response to both intranasal (Stimate<jats:sup>\u00ae<\/jats:sup>) and subcutaneous DDAVP administration was assessed. Rise in ristocetin cofactor activity (VWF:RCo)\u2003\u2265\u200340% at 90\u2010min post\u2010Stimate<jats:sup>\u00ae<\/jats:sup> and 1\u20132\u2003h after subcutaneous DDAVP was defined as initial response; response longevity was assessed only after subcutaneous dosing by measuring VWF:RCo levels at time\u2010points 1, 2, 4 and 6\u2003h. Eleven patients (five males, six females; age range: 20\u201356\u2003years) participated in intranasal and 9\/11 (four males, five females) in subcutaneous testing. Baseline haemostatic profiles included: VWF:RCo\u2003&lt;\u200315%, VWF:Ag\u2003&lt;\u200340% and normal VWF multimers. Initial response was comparable by both intranasal (6\/11; 54.5%) and subcutaneous (4\/9; 44%) routes; sustained response (VWF:RCo\u2003&gt;\u200340% for 2\u2003h) was observed in only one in nine (11%) patients tested. Median VWF:RCo peak levels after intranasal (40%) and subcutaneous (39%) routes were equivalent. Peak VWF:Ag levels were significantly higher after subcutaneous than intranasal DDAVP (94% vs. 54%; <jats:italic>P<\/jats:italic>\u2003=\u20030.03). Area under the curve for VWF:RCo was significantly decreased (170\u2003\u03bcg\u2003h\u2003mL<jats:sup>\u22121<\/jats:sup>) compared with VWF:Ag (471\u2003\u03bcg\u2003h\u2003mL<jats:sup>\u22121<\/jats:sup>) and FVIII:C (624.60\u2003\u03bcg\u2003h\u2003mL<jats:sup>\u22121<\/jats:sup>). This study suggests that in this population: (i) intra\u2010individual DDAVP response is consistent with subcutaneous and intranasal administration; and (ii) extending DDAVP challenge test up to at least 6\u2003h is required to characterize adequacy and longevity of biologic response prior to using DDAVP as a sole haemostatic intervention.<\/jats:p>","DOI":"10.1111\/j.1365-2516.2008.01666.x","type":"journal-article","created":{"date-parts":[[2008,2,26]],"date-time":"2008-02-26T02:56:36Z","timestamp":1203994596000},"page":"539-548","source":"Crossref","is-referenced-by-count":6,"title":["Biologic response to subcutaneous and intranasal therapy with desmopressin in a large Amish kindred with Type 2M von Willebrand disease"],"prefix":"10.1111","volume":"14","author":[{"given":"A.","family":"SHARTHKUMAR","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"GREIST","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"DI PAOLA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"WINAY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"ROBERSON","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"HEIMAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"HERBERT","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"PARAMESWARAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"SHAPIRO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,2,25]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(77)91197-7"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.7.1915"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V64.1.229.229"},{"key":"e_1_2_6_5_2","first-page":"662","article-title":"Studies on the prolonged bleeding time in von Willebrand\u2019s disease","volume":"88","author":"Mannucci PM","year":"1976","journal-title":"J Lab Clin Med"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1646050"},{"key":"e_1_2_6_7_2","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1055\/s-0038-1650645","article-title":"Prospective multicenter study on subcutaneous concentrated desmopressin for home treatment of patients with von Willebrand disease and mild or moderate hemophilia A","volume":"76","author":"Rodeghiero F","year":"1996","journal-title":"Thromb Haemost"},{"issue":"1","key":"e_1_2_6_8_2","first-page":"P1472","article-title":"A missense mutation in exon 28 (C4120T) of the von Willebrand factor gene is the cause for von Willebrand disease in a large Amish pedigree","volume":"3","author":"Di Paola JMJ","year":"2005","journal-title":"J Thromb Haemost"},{"key":"e_1_2_6_9_2","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1055\/s-0037-1613995","article-title":"Type 2M vWD resulting from a lysine deletion within a four lysine residue repeat in the A1 loop of von Willebrand factor","volume":"84","author":"Hilbert L","year":"2000","journal-title":"Thromb Haemost"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1053\/beha.2001.0134"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.3.1010.1010"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-05-020784"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-06-2072"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02666.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.01807.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01571.x"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lab.2004.08.002"},{"key":"e_1_2_6_18_2","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1160\/TH06-11-0647","article-title":"Altered von Willebrand factor subunit proteolysis and multimer processing associated with the Cys2362Phe mutation in the B2 domain","volume":"97","author":"Casonato A","year":"2007","journal-title":"Thromb Haemost"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1067\/mlc.2001.111252"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1987.tb03131.x"},{"key":"e_1_2_6_21_2","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1055\/s-0038-1661458","article-title":"Comparative study of intranasal, subcutaneous and intravenous administration of desamino\u2010d\u2010arginine vasopressin (DDAVP)","volume":"55","author":"Kohler M","year":"1986","journal-title":"Thromb Haemost"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1646051"},{"key":"e_1_2_6_23_2","first-page":"176","article-title":"A genome\u2010wide linkage scan of a large Amish pedigree with von Willebrand disease (VWD) identified several chromosomal regions that may contain potential modifiers of von Willebrand factor (VWF) levels and disease variability","volume":"106","author":"Di Paola J","year":"2006","journal-title":"Blood (ASH Annual Meeting Abstracts)"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.02146.x"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00535.x"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1615770"},{"key":"e_1_2_6_27_2","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1001\/jama.1976.03260440039020","article-title":"Pharmacokinetics in clinical practice. 2. Applications","volume":"235","author":"Gibaldi M","year":"1976","journal-title":"JAMA"},{"key":"e_1_2_6_28_2","unstructured":"http:\/\/www.humatep.com\/pdf\/HumateP_PI.pdf."},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.11124"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1080\/07853890701513738"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.11.4243"},{"key":"e_1_2_6_32_2","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1182\/blood.V73.4.990.990","article-title":"Possible effect of secretor locus on plasma concentration of factor VIII and von Willebrand factor","volume":"73","author":"Orstavik KH","year":"1989","journal-title":"Blood"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80964-2"}],"container-title":["Haemophilia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2516.2008.01666.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2516.2008.01666.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T09:40:06Z","timestamp":1697190006000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2516.2008.01666.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,25]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["10.1111\/j.1365-2516.2008.01666.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2516.2008.01666.x","archive":["Portico"],"relation":{},"ISSN":["1351-8216","1365-2516"],"issn-type":[{"value":"1351-8216","type":"print"},{"value":"1365-2516","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,25]]}}}